Breaking News Instant updates and real-time market news.

GKOS

Glaukos

$60.03

15.24 (34.03%)

11:53
08/29/18
08/29
11:53
08/29/18
11:53

Glaukos upgraded to Overweight from Neutral at JPMorgan

  • 05

    Sep

GKOS Glaukos
$60.03

15.24 (34.03%)

08/24/18
WELS
08/24/18
NO CHANGE
Target $50
WELS
Outperform
Ivantis counterclaim against Glaukos looks weak, says Wells Fargo
Following a review by his firm's patent consultant, Wells Fargo analyst Larry Biegelsen says Ivantis' counterclaim, alleging that Glaukos' new iStent inject product will infringe three Ivantis patents, appears weak. The Ivantis patents very specifically add a detail about the placement of the shunt, which reads as "too straightforward" or "obvious," the patent consultant told the analyst. As such, he believes the patents will ultimately be found invalid. Biegelsen keeps an Outperform rating on Glaukos with a $50 price target.
08/29/18
WBLR
08/29/18
NO CHANGE
WBLR
Outperform
CyPass market removal a 'clear positive' for Glaukos, says William Blair
William Blair analyst Brian Weinstein believes Alcon's voluntary global market withdrawal of its CyPass Micro-Stent for surgical glaucoma is a "clear positive for near-term numbers" at Glaukos (GKOS). If Glaukos' iStent takes all of the CyPass market share while it is off the market, the company could add as much as $50M in the U.S. alone to its 2019 total revenue of around $186M, Weinstein tells investors in a research note, while admitting this is a bullish stance. The analyst thinks the news this morning from Alcon should be viewed as a positive for Glaukos, as a major part of the short thesis was on competition in the core iStent market, mainly from Alcon. He keeps an Outperform rating on Glaukos shares.
08/29/18
PIPR
08/29/18
NO CHANGE
Target $55
PIPR
Overweight
Piper sees CyPass withdrawal as 'major boon' for Glaukos, ups target to $55
Piper Jaffray analyst Matt O'Brien views Alcon's immediate withdrawal of its CyPass stent for the treatment of glaucoma on safety concerns from a recently completed clinical study as a "major boon" for Glaukos (GKOS). The analyst suspects it will be several quarters before CyPass comes back to the market, with with a much narrower indication. This is a "major positive" for Glaukos as most of the clinicians using CyPass had been or are still using iStent from Glaukos, O'Brien tells investors in a research note. He anticipates many clinicians will quickly shift their volumes back to iSten, yielding "significant incremental revenues." Based on this morning's news, the analyst raised his price target for Glaukos shares to $55 from $46. He encourages investors to start or build positions in the name.
08/29/18
SPHN
08/29/18
NO CHANGE
Target $57
SPHN
Overweight
Glaukos price target raised to $57 at Stephens after Novartis withdraws CyPass
Stephens analyst Chris Cooley raised his price target on Glaukos (GKOS) shares to $57 from $50 after Novartis' (NVS) Alcon unit withdrew the CyPass micro-stent from the market due to safety concerns. He estimates $40M-$50M in annual sales are now "in play" and see Glaukos as the most likely beneficiary, Cooley tells investors. He maintains an Overweight rating on Glaukos shares, which are up $17.35, or 39%, to $62.15 in pre-market trading.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,945.74

19.47 (1.01%)

13:13
09/20/18
09/20
13:13
09/20/18
13:13
Periodicals
Amazon says Alexa now includes over 50,000 skills, CNet reports »

At a company event,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SYK

Stryker

$172.66

-0.93 (-0.54%)

13:13
09/20/18
09/20
13:13
09/20/18
13:13
Hot Stocks
Stryker to showcase Tritanium In-Growth Technology in AR experience »

Stryker's Spine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

TTPH

Tetraphase

$3.02

(0.00%)

13:12
09/20/18
09/20
13:12
09/20/18
13:12
Hot Stocks
Tetraphase announces EC decision granting marketing authorization for XERAVA »

Tetraphase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

AMZN

Amazon.com

$1,946.42

20.15 (1.05%)

13:11
09/20/18
09/20
13:11
09/20/18
13:11
Periodicals
Amazon making Alexa 'more knowledgable' and 'more conscientious,' CNet says »

At a company event,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ADBE

Adobe

$268.13

3.22 (1.22%)

, CRM

Salesforce

$155.05

2.17 (1.42%)

13:11
09/20/18
09/20
13:11
09/20/18
13:11
Periodicals
Adobe close to acquiring Marketo for around $5B, CNBC reports »

Adobe Systems (ADBE) is…

ADBE

Adobe

$268.13

3.22 (1.22%)

CRM

Salesforce

$155.05

2.17 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 03

    Mar

ADBE

Adobe

$268.25

3.34 (1.26%)

13:08
09/20/18
09/20
13:08
09/20/18
13:08
Periodicals
Breaking Periodicals news story on Adobe »

Adobe nears $5B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:07
09/20/18
09/20
13:07
09/20/18
13:07
General news
10-Yr TIPS Auction Coupon Rate data reported »

10-Yr TIPS Auction Coupon…

13:07
09/20/18
09/20
13:07
09/20/18
13:07
General news
10-Yr TIPS Auction Total Amount data reported »

10-Yr TIPS Auction Total…

JD

JD.com

$26.94

0.01 (0.04%)

13:06
09/20/18
09/20
13:06
09/20/18
13:06
Periodicals
Prosecutors weighing whether to bring charges against JD.com CEO, Reuters says »

Minneapolis prosecutors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$28.37

0.48 (1.72%)

13:00
09/20/18
09/20
13:00
09/20/18
13:00
Options
Notable call buy in KKR as shares reach new highs highs »

Notable call buy in KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:00
09/20/18
09/20
13:00
09/20/18
13:00
General news
Treasury Action: curve narrowing is back in play as the front end underperforms »

Treasury Action: curve…

13:00
09/20/18
09/20
13:00
09/20/18
13:00
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

12:55
09/20/18
09/20
12:55
09/20/18
12:55
Conference/Events
SEC to hold a closed commission meeting »

Closed Commission Meeting…

MU

Micron

$46.49

1.44 (3.20%)

, UMC

UMC

$2.49

-0.015 (-0.60%)

12:41
09/20/18
09/20
12:41
09/20/18
12:41
Earnings
Fly Intel: What to watch for in Micron's earnings report »

Micron (MU) is scheduled…

MU

Micron

$46.49

1.44 (3.20%)

UMC

UMC

$2.49

-0.015 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

SWN

Southwestern Energy

$5.61

0.105 (1.91%)

12:40
09/20/18
09/20
12:40
09/20/18
12:40
Options
Aggressive call buying in Southwest Energy »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ACAD

Acadia

$15.14

0.03 (0.20%)

12:37
09/20/18
09/20
12:37
09/20/18
12:37
Hot Stocks
Acadia jumps after FDA finds no new or unexpected safety risks for Nuplazid »

Shares of Acadia (ACAD)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

GOOG

Alphabet

$1,185.51

14.54 (1.24%)

, GOOGL

Alphabet Class A

$1,189.61

14.95 (1.27%)

12:37
09/20/18
09/20
12:37
09/20/18
12:37
Periodicals
Google tells U.S. lawmakers apps can still scan emails for data, WSJ reports »

Alphabet's Google…

GOOG

Alphabet

$1,185.51

14.54 (1.24%)

GOOGL

Alphabet Class A

$1,189.61

14.95 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 03

    Mar

SSNLF

Samsung

$0.00

(0.00%)

12:36
09/20/18
09/20
12:36
09/20/18
12:36
Periodicals
Samsung to lower memory chip growth amid looming demand slowdown, Bloomberg says »

Samsung Electronics is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$1.33

0.005 (0.38%)

12:28
09/20/18
09/20
12:28
09/20/18
12:28
Periodicals
Several people dead in shooting at Rite Aid facility in Maryland, NY Times says »

A person with a gun fired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

ACAD

Acadia

$15.14

0.03 (0.20%)

12:27
09/20/18
09/20
12:27
09/20/18
12:27
Periodicals
Breaking Periodicals news story on Acadia »

FDA finds no new,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ACAD

Acadia

$15.14

0.03 (0.20%)

12:25
09/20/18
09/20
12:25
09/20/18
12:25
Hot Stocks
Breaking Hot Stocks news story on Acadia »

Acadia jumps 17%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

I

Intelsat

$22.40

0.22 (0.99%)

12:25
09/20/18
09/20
12:25
09/20/18
12:25
Options
Intelsat call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWRE

Guidewire

$101.75

0.2 (0.20%)

12:25
09/20/18
09/20
12:25
09/20/18
12:25
Conference/Events
Guidewire to host analyst day »

Analyst Day to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
09/20/18
09/20
12:17
09/20/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCI

Rogers Communications

$52.08

0.41 (0.79%)

12:17
09/20/18
09/20
12:17
09/20/18
12:17
Hot Stocks
Rogers, UBC sign multi-year agreement to build 5G hub in Vancouver »

Rogers and the University…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.